740 related articles for article (PubMed ID: 17206665)
1. Expression and functional characterization of FOXP3+ CD4+ regulatory T cells in ulcerative colitis.
Yu QT; Saruta M; Avanesyan A; Fleshner PR; Banham AH; Papadakis KA
Inflamm Bowel Dis; 2007 Feb; 13(2):191-9. PubMed ID: 17206665
[TBL] [Abstract][Full Text] [Related]
2. T-cell receptor sequencing reveals the clonal diversity and overlap of colonic effector and FOXP3+ T cells in ulcerative colitis.
Lord J; Chen J; Thirlby RC; Sherwood AM; Carlson CS
Inflamm Bowel Dis; 2015 Jan; 21(1):19-30. PubMed ID: 25437819
[TBL] [Abstract][Full Text] [Related]
3. Increased CD4
Ma YH; Zhang J; Chen X; Xie YF; Pang YH; Liu XJ
World J Gastroenterol; 2016 Nov; 22(42):9356-9367. PubMed ID: 27895423
[TBL] [Abstract][Full Text] [Related]
4. Basal lymphoid aggregates in ulcerative colitis colon: a site for regulatory T cell action.
Sitohy B; Hammarström S; Danielsson A; Hammarström ML
Clin Exp Immunol; 2008 Feb; 151(2):326-33. PubMed ID: 18190460
[TBL] [Abstract][Full Text] [Related]
5. Lamina Propria CD4+LAP+ Regulatory T Cells Are Increased in Active Ulcerative Colitis but Show Increased IL-17 Expression and Reduced Suppressor Activity.
D'Ambrosio A; Cossu A; Amendola A; Zandri A; Butera A; Sanchez M; Biffoni M; Pronio A; Montesani C; Kohn A; Pica R; Boirivant M
J Crohns Colitis; 2016 Mar; 10(3):346-53. PubMed ID: 26589955
[TBL] [Abstract][Full Text] [Related]
6. FoxP3(+)CD4(+)CD25(+) T cells with regulatory properties can be cultured from colonic mucosa of patients with Crohn's disease.
Kelsen J; Agnholt J; Hoffmann HJ; Rømer JL; Hvas CL; Dahlerup JF
Clin Exp Immunol; 2005 Sep; 141(3):549-57. PubMed ID: 16045746
[TBL] [Abstract][Full Text] [Related]
7. Characterization of FOXP3+CD4+ regulatory T cells in Crohn's disease.
Saruta M; Yu QT; Fleshner PR; Mantel PY; Schmidt-Weber CB; Banham AH; Papadakis KA
Clin Immunol; 2007 Dec; 125(3):281-90. PubMed ID: 17897887
[TBL] [Abstract][Full Text] [Related]
8. Profiles of Lamina Propria T Helper Cell Subsets Discriminate Between Ulcerative Colitis and Crohn's Disease.
Li J; Ueno A; Fort Gasia M; Luider J; Wang T; Hirota C; Jijon HB; Deane M; Tom M; Chan R; Barkema HW; Beck PL; Kaplan GG; Panaccione R; Qian J; Iacucci M; Gui X; Ghosh S
Inflamm Bowel Dis; 2016 Aug; 22(8):1779-92. PubMed ID: 27243594
[TBL] [Abstract][Full Text] [Related]
9. Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4+ T cells and defective suppressive function of circulating Foxp3+ regulatory cells support plasticity between Th17 and regulatory T cells in inflammatory bowel disease patients.
Ueno A; Jijon H; Chan R; Ford K; Hirota C; Kaplan GG; Beck PL; Iacucci M; Fort Gasia M; Barkema HW; Panaccione R; Ghosh S
Inflamm Bowel Dis; 2013 Nov; 19(12):2522-34. PubMed ID: 24097227
[TBL] [Abstract][Full Text] [Related]
10. Crossover Subsets of CD4
Li J; Ueno A; Iacucci M; Fort Gasia M; Jijon HB; Panaccione R; Kaplan GG; Beck PL; Luider J; Barkema HW; Qian J; Gui X; Ghosh S
Dig Dis Sci; 2017 Sep; 62(9):2357-2368. PubMed ID: 28573508
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-17 immunity in pediatric Crohn disease and ulcerative colitis.
Hölttä V; Klemetti P; Salo HM; Koivusalo A; Pakarinen M; Westerholm-Ormio M; Kolho KL; Vaarala O
J Pediatr Gastroenterol Nutr; 2013 Sep; 57(3):287-92. PubMed ID: 23974060
[TBL] [Abstract][Full Text] [Related]
12. Determination of a CD4
Jafarinia M; Mehdipour F; Hosseini SV; Ghahramani L; Hosseinzadeh M; Ghaderi A
Tumour Biol; 2016 Nov; 37(11):14659-14666. PubMed ID: 27619682
[TBL] [Abstract][Full Text] [Related]
13. Suppressive and Gut-Reparative Functions of Human Type 1 T Regulatory Cells.
Cook L; Stahl M; Han X; Nazli A; MacDonald KN; Wong MQ; Tsai K; Dizzell S; Jacobson K; Bressler B; Kaushic C; Vallance BA; Steiner TS; Levings MK
Gastroenterology; 2019 Dec; 157(6):1584-1598. PubMed ID: 31513797
[TBL] [Abstract][Full Text] [Related]
14. Over-expression of interleukin 10 in mucosal T cells of patients with active ulcerative colitis.
Melgar S; Yeung MM; Bas A; Forsberg G; Suhr O; Oberg A; Hammarstrom S; Danielsson A; Hammarstrom ML
Clin Exp Immunol; 2003 Oct; 134(1):127-37. PubMed ID: 12974765
[TBL] [Abstract][Full Text] [Related]
15. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro.
Chen JF; Gao J; Zhang D; Wang ZH; Zhu JY
Chin Med J (Engl); 2010 Apr; 123(7):942-8. PubMed ID: 20497692
[TBL] [Abstract][Full Text] [Related]
16. Impaired control of effector T cells by regulatory T cells: a clue to loss of oral tolerance and autoimmunity in celiac disease?
Hmida NB; Ben Ahmed M; Moussa A; Rejeb MB; Said Y; Kourda N; Meresse B; Abdeladhim M; Louzir H; Cerf-Bensussan N
Am J Gastroenterol; 2012 Apr; 107(4):604-11. PubMed ID: 22108452
[TBL] [Abstract][Full Text] [Related]
17. [Effect of human bone marrow mesenchymal stem cells on allogeneic regulatory T cells and its possible mechanism].
Yang J; Wang QH; Zeng QT; Mao XB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):785-9. PubMed ID: 17708804
[TBL] [Abstract][Full Text] [Related]
18. Decrease of CD4(+) CD25(+) CD127(low) FoxP3(+) regulatory T cells with impaired suppressive function in untreated ulcerative colitis patients.
Mohammadnia-Afrouzi M; Zavaran Hosseini A; Khalili A; Abediankenari S; Hosseini V; Maleki I
Autoimmunity; 2015; 48(8):556-61. PubMed ID: 26333292
[TBL] [Abstract][Full Text] [Related]
19. Immunoregulatory pathways are active in the small intestinal mucosa of patients with potential celiac disease.
Borrelli M; Salvati VM; Maglio M; Zanzi D; Ferrara K; Santagata S; Ponticelli D; Aitoro R; Mazzarella G; Lania G; Gianfrani C; Auricchio R; Troncone R
Am J Gastroenterol; 2013 Nov; 108(11):1775-84. PubMed ID: 24060758
[TBL] [Abstract][Full Text] [Related]
20. CD4+CD25bright T cells in human intestinal lamina propria as regulatory cells.
Makita S; Kanai T; Oshima S; Uraushihara K; Totsuka T; Sawada T; Nakamura T; Koganei K; Fukushima T; Watanabe M
J Immunol; 2004 Sep; 173(5):3119-30. PubMed ID: 15322172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
